Treading window Closure for the Quarter ending 30th June 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Oxygenta Pharmaceutical Ltd has announced the closure of its insider trading window for the quarter ending 30th June 2025, in compliance with SEBI's Prohibition of Insider Trading Regulations. During this period, designated persons including directors, key managerial personnel, and other insiders are prohibited from trading in the company's shares. The closure typically precedes the announcement of quarterly financial results and the window generally reopens 48 hours after the results are made public.
This is a routine regulatory compliance filing and does not directly impact shareholders. It signals that Q1 FY2025-26 results are likely to be announced soon, which investors should watch for as it may contain material performance information.